Variability of the in vitro activity of proguanil and cycloguanil on the erytrocyte stages of plasmodium falciparum according to conditions of culture;Variabilité de l'activité in vitro du proguanil et du cycloguanil sur les stades érythrocytaires de Plasmodium falciparum en fonction des conditions de culture

Bulletin de la Societe de Pathologie Exotique

Volumn 92, Issue 5, 1999, Pages 313-316

  Ndounga, M ^a,b   Basco, L K ^b   Ringwald, P ^b  

^a Laboratoire de Pharmacologie   (Congo)

^b Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

Author keywords

Antifolate; Biguanide; Chloroquine; Cycloguanil; Dihydrofolate reductase; In vitro test; Malaria; Plasmodium falciparum; Proguanil; Sub saharan Africa

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; CYCLOGUANIL; PROGUANIL; TRIAZINE DERIVATIVE;

ANIMAL; ARTICLE; CELL CULTURE; CULTURE MEDIUM; DRUG EFFECT; DRUG RESISTANCE; ERYTHROCYTE; GROWTH, DEVELOPMENT AND AGING; HUMAN; PARASITOLOGY; PLASMODIUM FALCIPARUM;

ANIMALS; ANTIMALARIALS; CELLS, CULTURED; CHLOROGUANIDE; CHLOROQUINE; CULTURE MEDIA; DRUG RESISTANCE; ERYTHROCYTES; HUMANS; PLASMODIUM FALCIPARUM; TRIAZINES;

EID: 0033257157     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. ANG HH, CHAN KL & MAK JW - Susceptibility studies of Plasmodium falciparum isolates and clones against cycloguanil and pyrimethamine using the modified in vitro microtechnique. J Parasitol, 1996, 82, 1029-1031.
2. BASCO LK, RAMILIARISOA O & LE BRAS J - In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg, 1994, 50, 193-199.
3. BERENBAUM MC - A method for testing for synergy with any number of agents. J Infect Dis, 1978, 137, 122-130.
4. CANFIELD CJ, PUDNEY M & GUTTERIDGE WE - Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp Parasitol, 1995, 80, 373-381.
5. CORTESE JF & PLOWE CV - Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed by yeast. Mol Biochem Parasitol, 1998, 94, 205-214.
6. CURD FHS, DAVEY DG & ROSE FL - Studies on antimalarial drug. X. Some biguanides derivatives as new types of antimalarial substances with both therapeutic and causal prophylactic activity. Ann Trop Med Parasitol, 1945, 39, 208-216.
7. EDSTEIN MD, VEENENDAAL JR, SCOTT HV & RIECKMANN KM -Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man. Chemotherapy, 1988, 34, 385-392.
8. ERIKSSON B, LEBBAD M & BJORKMAN A - In vitro activity of proguanil, chlorproguanil and their main metabolite against Plasmodium falciparum. Trans R Soc Trop Med Hyg, 1989, 83, 488.
9. FIDOCK DA & WELLEMS TE - Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. Proc Natl Acad Sci USA, 1997, 94, 10931-10936.
10. FIDOCK DA, NOMURA T & WELLEMS TE - Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase. Mol Pharmacol, 1998, 54, 1140-1147.
11. FOOTE SJ, GALATAS D & COWMAN AF - Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci USA, 1990, 87, 3014-3017.
12. HOSKINS JM, SHENFIELD GM & GROSS AS - Relationship between proguanil metabolic ratio and CYP2C19 genotype in a Caucasian population. Br J Clin Pharmacol, 1998, 46, 499-504.
13. KANEKO A, BERGQVIST Y, KALKOA M, KANEKO O, KOBAYAKAWA T et al - Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil. J Infect Dis, 1999, 179, 974-979.
14. MBERU EK, WANSOR T, SATO H, NISHIKAWA Y & WATKINS WM -Japanese poor metabolizers of proguanil do not have an increased risk of malaria chemoprophylaxis breakthough. Trans R Soc Trop Hyg, 1995, 89, 658-659.
15. MILHOUS WK, WEATHERLY NF, BOWDRE JH & DESJARDINSRE -In vitro activities of and mechanisms of resistance to antifol antimalarial drugs. Antimicrob Agents Chemother, 1985, 27, 525-530.
16. MOUNT DL, NAHLEN BL, PATCHEN LC & CHURCHILL FC - Adaptations of the Saker-Solomons test: Simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bull World Health Organ, 1989, 67, 295-300.
17. PETERSEN E, HOGH B, HANSON AP, BJORKMAN A & H FLACKS -In vitro and in vivo susceptibility of Plasmodium falciparum isolates from Liberia to pyrimethamine, cycloguanil and chlorcycloguanil. Ann Trop Med Parasitol, 1990, 84, 563-571.
18. RADLOFF PD, PHILIPPS J, NKEYI M, HUTCHINSON D, KREMSNER PG -Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet. 1996, 347, 1511-1514.
19. RINGWALD P & BASCO LK - Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaoundé, Cameroon. Bull World Health Organ, 1999, 77, 34-43.
20. RINGWALD P, BICKII J & BASCO LK - In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon. Am J Trop Med Hyg 1996, 55, 254-258.
21. SCHAPIRA A, BYGBJERG IC, JEPSEN S, FLACHS H & BENTZON MW -The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results. Am J Trop Med Hyg, 1986, 35, 239-245.
22. SIXSMITH DG, WATKINS WM, CHULAY JD & SPENCER HC - In vitro antimalarial activity of tetrahydrofalate dehydrogenase inhibitors. Am J Trop Med Hyg, 1984, 33, 772-776.
23. TRAGER W & JENSEN JB - Human malaria parasites in continuous culture. Science, 1976, 193, 673-675.
24. TSOKA JM, FREESE JA, ROSSOUW EJ, SHARP BL & APPLETON CC -Action of the chloroquine/pyrimethamine combination on southern African isolates of Plasmodium falciparum in vitro. S Afr J Sci, 1997, 93, 295-296.
25. WARD SA, HELSBY NA, SKJELBO E, BROSEN K, GRAM LF & BREKENRIDGE AM - The activation of the biguanide antimalarial proguanil co-segregates with mephenytoin oxidation polymorphism - a panel study. Br J Clin Pharmacol, 1991, 31, 689-692.
26. WATKINS WM, SIXSMITH DG & CHULAY JD - The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro. Ann Trop Med Parasitol, 1984, 78, 273-278.
27. WATKINS WM, SIXSMITH DG, CHULAY JD & SPENCER HC - Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid. Mol Biochem Parasitol, 1985, 14, 55-61.
28. WHITE NJ - Preventing antimalarial drug resistance through combinations. Drug Res Updates, 1998, 1, 3-9.